Graham Capital Management, L.P. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q4 2022$9,601,100
+341.6%
335,000
+353.9%
0.29%
+163.1%
Q3 2021$2,174,000
-74.4%
73,800
-70.5%
0.11%
-75.1%
Q2 2021$8,495,000
+30.7%
250,000
+25.0%
0.44%
+54.0%
Q1 2021$6,500,000
+0.3%
200,000
+11.1%
0.29%
+21.4%
Q4 2020$6,483,000
-45.6%
180,000
-44.6%
0.24%
-58.5%
Q2 2020$11,915,000
+113.8%
324,852
+34.3%
0.57%
+45.8%
Q1 2020$5,572,000
+895.0%
241,852
+867.4%
0.39%
+1210.0%
Q1 2019$560,000
-73.7%
25,000
-78.3%
0.03%
-31.8%
Q3 2018$2,129,000
-77.8%
115,000
-73.3%
0.04%
-87.7%
Q2 2018$9,593,000
-70.9%
430,000
-71.3%
0.36%
-59.5%
Q1 2018$32,970,000
+72.2%
1,500,000
+82.1%
0.88%
+76.6%
Q4 2017$19,142,000
-45.9%
823,661
-46.6%
0.50%
-32.8%
Q3 2017$35,387,000
+146.6%
1,541,258
+137.1%
0.74%
+97.6%
Q2 2017$14,352,000
+529.2%
650,000
+550.0%
0.38%
+317.8%
Q1 2017$2,281,000
-96.7%
100,000
-96.2%
0.09%
-95.9%
Q3 2016$68,718,000
+404.1%
2,600,000
+428.3%
2.21%
+215.1%
Q2 2016$13,631,000492,1000.70%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2018
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders